Search Results

Disclosure ref 2024267 - invoices relating to Bolsover hospital.pdf

Freedom of information disclosure relating to Invoices, including supplier, value and dates for medical gases supplied to Bolsover community since 2019 to date of FOI request

Disclosure Ref 2024245 - Collabrative working with pharmaceutical companies.doc

Disclosure Ref 2024245 - Collaborative working with pharmaceutical companies

Disclosure Ref 2025285 - Procurement & contract information.pdf

Freedom of information disclosure relating to details of any ongoing procurement exercises or tenders, estimated contract values and duration and Key procurement contact details

8540-My-Community-Autumn-2019-V5-ONLINE.pdf

My Community Autumn 2019

Screen shots for opening one patient record at a time on SystmOne draft.docx

Missing from Known Address Policy (P71)

The purpose of the Missing Children and family Alert (MCFA) process is to locate pregnant women and children who have disappeared from view following an undisclosed change of address and for whom there may be concerns about child welfare in respect of unmet need, vulnerability or abuse. Working Together to Safeguard Children (HM Government 2018) identifies that all children should be safeguarded and have their welfare promoted. This Policy is aimed at DCHS Services that hold a child caseload.

Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)

The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.

Employee online user guide - temporary staffing.pdf

Disclosure Ref 202243 - Agency for Biomedical SciencePathology - Copy.pdf

WRES data report 2023.docx